Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GBT

Global Blood Therapeutics (GBT) Stock Price, News & Analysis

Global Blood Therapeutics logo

About Global Blood Therapeutics Stock (NASDAQ:GBT)

Advanced Chart

Key Stats

Today's Range
$68.49
$68.49
50-Day Range
$68.07
$68.49
52-Week Range
$21.65
$73.02
Volume
74 shs
Average Volume
2.07 million shs
Market Capitalization
$4.62 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Blood Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

GBT Stock News Headlines

Global Blood Therapeutics Inc (GBT)
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
GBT Technologies to acquire Nexus Workspaces from CGI
See More Headlines

GBT Stock Analysis - Frequently Asked Questions

Global Blood Therapeutics, Inc. (NASDAQ:GBT) posted its quarterly earnings results on Thursday, November, 4th. The company reported ($1.13) EPS for the quarter, missing the consensus estimate of ($1.10) by $0.03. The company's revenue was up 41.1% on a year-over-year basis.

Global Blood Therapeutics (GBT) raised $102 million in an IPO on Wednesday, August 12th 2015. The company issued 6,000,000 shares at $16.00-$18.00 per share. Morgan Stanley and Goldman Sachs served as the underwriters for the IPO and Cowen and Company and Wedbush PacGrow were co-managers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Global Blood Therapeutics investors own include NVIDIA (NVDA), Micron Technology (MU), Alibaba Group (BABA), Meta Platforms (META), Intel (INTC), Bristol Myers Squibb (BMY) and Advanced Micro Devices (AMD).

Company Calendar

Last Earnings
11/04/2021
Today
7/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GBT
CIK
1629137
Fax
N/A
Employees
457
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($5.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$303.09 million
Net Margins
-137.30%
Pretax Margin
-137.01%
Return on Equity
-170.37%
Return on Assets
-39.24%

Debt

Debt-to-Equity Ratio
4.92
Current Ratio
6.88
Quick Ratio
6.17

Sales & Book Value

Annual Sales
$194.75 million
Price / Sales
23.73
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
22.46

Miscellaneous

Outstanding Shares
67,476,000
Free Float
64,170,000
Market Cap
$4.62 billion
Optionable
Optionable
Beta
0.45

Social Links

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:GBT) was last updated on 7/15/2025 by MarketBeat.com Staff
From Our Partners